Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Oladipupo Olafiranye, MD MS
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Va Pittsburgh Healthcare System University Drive Division, Pittsburgh, Pa
Pittsburgh, Pennsylvania, United States
Recruiting - Va North Texas Health Care System Dallas Va Medical Center, Dallas, Tx
Dallas, Texas, United States
Oladipupo Olafiranye, MD MSRecruiting - Hunter Holmes Mcguire Va Medical Center, Richmond, Va
Richmond, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2021
- Primary completion
- 31 Mar 2028
- Completion
- 31 Mar 2029
- Last update posted
- 15 Dec 2025
- Registered enrollment
- 240
- Registry id
- NCT04982419
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.